Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB

Nutrition

Volumn 27, Issue 7-8, 2011, Pages 816-823

  Prasad, Ananda S ^a   Bao, Bin ^a   Beck, Frances W J ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Interleukin 1 ; Nuclear factor B; Tumor necrosis factor ; Zinc, A20

Indexed keywords

I KAPPA B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN A20; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CANCER CELL; CELL LINE; CELL STIMULATION; CELL STRAIN HL 60; CELL STRAIN SW480; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL LINE; CYTOKINES; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; ZINC;

EID: 79959266274     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.08.010     Document Type: Article

References (23)

1. Castro L., Freeman B.A. Reactive oxygen species in human health and disease. Nutrition 2001, 17:161-165.
2. Lachance P.A., Nakat Z., Jeong W. Antioxidants: An integrative approach. Nutrition 2001, 17:835-838.
3. Opal S.M., DePalo V.A. Impact of basic research on tomorrow's medicine: Anti-Inflammatory cytokines. Chest 2002, 117:1162-1172.
4. Hennig B., Meerarani P., Toborek M., McClain C.J. Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 1999, 18:152-158.
5. Ho E., Courtemanche C., Ames B.N. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 2003, 133:2543-2548.
6. Aggarwal B.B. Nuclear factor-κB: the enemy within. Cancer Cell 2004, 6:203-208.
7. Von Bulow V., Dubben S., Engelhardt G., Hebel S., Plumakers B., Heine H., et al. Zinc dependant suppression of TNF-α production is mediated by protein kinase A-induced inhibition of Raf-1, IκB kinases B and NF-κB. J Immunol 2007, 179:4180-4186.
8. Karin M., Gretem F.R. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
9. Lee E.G., Boone D.L., Chai S., Libby S.H., Chien M., Lodoice J.P., Ma A. Failure to regulate TNF-induced NF-κB and cell death responses in A20 deficient mice. Science 2000, 289:2350-2354.
10. Prasad A.S., Bao B., Beck F.W.J., Sarkar F.H. Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-κB activation. J Lab Clin Med 2002, 140:272-289.
11. Song H.Y., Rothe M., Goeddel D.V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. PNAS 1996, 93:6721-6725.
12. Heyninck K., Beyaert R. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6. FEBS Lett 1999, 442:147-150.
13. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 1996, 156:1166-1173.
14. Bao B., Prasad A.S., Beck F.W., Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol:Endocrinol Metab 2003, 285:E1095-E1102.
15. Bao B., Prasad A.S., Beck F.W.J., Snell D., Suneja A., Sarkar F.H., et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Translational Res 2008, 152:67-80.
16. Prasad A.S., Beck F.W.J., Fitzgerald J.T., Snell D.C., Steinbert J.D., Cardozo L.J. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85:837-844.
17. Prasad A.S., Bao B., Beck F.W.J., Kucuk O., Sarkar F.H. Anti-oxidant effect of zinc humans. Free Radic Biol Med 2004, 37:1182-1190.
18. Clemons T.E., Kurinij N., Sperduto R.D. AREDS Research Group. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004, 122:716-726.
19. Von Bulow V., Rink L., Hasse H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-α and IL-1β production in monocytes by elevation of guanosine 3,5-cyclic monophosphate. J Immunol 2005, 175:4697-4705.
20. Cousins R.J., Blanchard R.K., Popp M.P., Liu L., Cao J., Moore J.B. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. PNAS 2003, 100:6952-6957.
21. Fukaya N., Mochizuki K., Shimeda M., Goda I. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes. Nutrition 2009, 25:657-667.
22. Hofamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman M.F. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity induced insulin resistance. Science 1996, 271:665-668.
23. Pai L.H., Prasad A.S. Cellular zinc in patients with diabetes mellitus. Nutr Res 1988, 8:889-897.